The combination of a Retinoid X Receptor (RXR) agonist LGD1069 (bexarotene) and vinorelbine produce synergistic growth inhibitory activity in non-small-cell lung cancer (NSCLC) cell lines

Abstract only

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 22; no. 14_suppl; p. 7358
Main Authors Bissonnette, R. P., Tooker, P., Hermann, T., Fan, B., Roegner, K., Yen, W.-C., Negro-Vilar, A., Lamph, W. W.
Format Journal Article
LanguageEnglish
Published 15.07.2004
Online AccessGet full text

Cover

More Information
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/jco.2004.22.90140.7358